Tempus stock price edged 0

Tempus stock price edged 0.9% higher on Tuesday, following industry news on AI-driven drug discovery partnerships. Institutional investors have steadily increased positions, raising the float ownership above 65%, a bullish underlying signal for upcoming quarters. Shares of Tempus AI Inc (NASDAQ: TEM ) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know . Regulatory approvals for each AI tool are slow, and new data privacy laws may bring hefty fines. The company is also still unprofitable with high R&D spending, meaning it may need to raise more capital, diluting shareholders. Competition is intense—from giants like Roche and tech titans like Google with deep pockets. And its valuation is steep: a $15 billion market cap on $1.3 billion in 2025 revenue. Any stumble has the potential to send its stock plunging, making that 10x dream a long shot. Market depth indicators reveal solid bid-ask stability for Tempus stock price during volatile sessions, suggesting institutional order flow dominance that tempers sharp downside risks.